Evaluation of thrombotic events in patients with immune thrombocytopenia-Reference-Cited by-同舟云学术

Evaluation of thrombotic events in patients with immune thrombocytopenia

Published:2019-12-18 Issue:1 Volume:99 Page:49-55
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Ito Shoko^ORCID,Fujiwara Shin-ichiro,Ikeda Takashi,Toda Yumiko,Mashima Kiyomi,Umino Kento,Minakata Daisuke,Nakano Hirofumi,Yamasaki Ryoko,Kawasaki Yasufumi,Sugimoto Miyuki,Ashizawa Masahiro,Yamamoto Chihiro,Hatano Kaoru,Sato Kazuya,Oh Iekuni,Ohmine Ken,Muroi Kazuo,Kanda Yoshinobu

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-019-03886-6.pdf

Reference22 articles.

1. Nugent D, McMillan R, Nichol JL, Slichter SJ (2009) Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br J Haematol 146:585–596

2. Machin N, Ragni MV, Comer DM, Yabes JG (2018) Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: an NIS study. Thromb Res 172:80–85

3. Cines DB, Bussel JB, Liebman HA, Luning Prak ET (2009) The ITP syndrome: pathogenic and clinical diversity. Blood. 113:6511–6521

4. Girolami A, de Marinis GB, Bonamigo E, Treleani M, Vettore S (2013) Arterial and venous thromboses in patients with idiopathic (immunological) thrombocytopenia: a possible contributing role of cortisone-induced hypercoagulable state. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 19:613–618

5. Ruggeri M, Tosetto A, Palandri F et al (2014) Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors. Journal of thrombosis and haemostasis : JTH 12:1266–1273

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune thrombocytopenia increases the risk of thrombosis: A two-sample Mendelian randomization study;International Journal of Cardiology;2024-11

2. The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?;Thrombosis Research;2024-09

3. Analysis of Risk Factors and the Establishment of a Predictive Model for Thrombosis in Patients with immune thrombocytopenia;2024-08-22

4. Uso de romiplostim en trombocitopenia inmunitaria: experiencia en Cuenca (Ecuador);Biomédica;2024-05-31

5. The Incidence and Characteristics of Thrombosis in Patients with Immune thrombocytopenia: A Retrospective Cohort Study;International Journal of General Medicine;2024-05